Cited by 107Genetics and Neurodevelopmental DisordersEpigenetics and DNA MethylationGenomics and Chromatin Dynamics

A Distinct DNA-Methylation Boundary in the 5′- Upstream Sequence of the FMR1 Promoter Binds Nuclear Proteins and Is Lost in Fragile X Syndrome

Open access
Naumann, Anja, Hochstein, Norbert, Weber, Stefanie, Fanning, Ellen, Doerfler, Walter·2009·The American Journal of Human Genetics

Abstract

We have discovered a distinct DNA-methylation boundary at a site between 650 and 800 nucleotides upstream of the CGG repeat in the first exon of the human FMR1 gene. This boundary, identified by bisulfite sequencing, is present in all human cell lines and cell types, irrespective of age, gender, and developmental stage. The same boundary is found also in different mouse tissues, although sequence homology between human and mouse in this region is only 46.7%. This boundary sequence, in both the unmethylated and the CpG-methylated modes, binds specifically to nuclear proteins from human cells. We interpret this boundary as carrying a specific chromatin structure that delineates a hypermethylated area in the genome from the unmethylated FMR1 promoter and protecting it from the spreading of DNA methylation. In individuals with the fragile X syndrome (FRAXA), the methylation boundary is lost; methylation has penetrated into the FMR1 promoter and inactivated the FMR1 gene. In one FRAXA genome, the upstream terminus of the methylation boundary region exhibits decreased methylation as compared to that of healthy individuals. This finding suggests changes in nucleotide sequence and chromatin structure in the boundary region of this FRAXA individual. In the completely de novo methylated FMR1 promoter, there are isolated unmethylated CpG dinucleotides that are, however, not found when the FMR1 promoter and upstream sequences are methylated in vitro with the bacterial M-SssI DNA methyltransferase. They may arise during de novo methylation only in DNA that is organized in chromatin and be due to the binding of specific proteins.

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2009.09.018

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In fragile X syndrome, cytosines up to about 1 kb upstream of the CGG repeats, including the FMR1 promoter, are methylated.

    “In FXS, cytosines located approximately up to 1-kb upstream of the CGG repeat sequences, including the FMR1 promoter, are methylated (14,15).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Naumann, A., Hochstein, N., Weber, S., Fanning, E., & Doerfler, W.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Vanderbilt University (US)
  • University of Cologne (DE)
Corresponding author
Doerfler, Walter
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2009-11
Volume
85
Issue
5
Pages
606-616
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2089579982
Cited by
107
References
44
Citations by year
2026: 2 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 10 · 2015: 5 · 2014: 8 · 2013: 11 · 2012: 7
FWCI
4.87
Type
journal article
Language
en
Update notices
erratum (2010-01-08)
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • FRAXA Research Foundation
  • National Institute of General Medical Sciences (GM-52948, R01GM052948)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
FMR1 gene, fragile X syndrome, DNA methylation, promoter, CGG repeat, nuclear protein binding, chromatin structure, CpG methylation, de novo methylation, gene silencing
MeSH terms
Adult, Animals, Base Sequence, Cell Line, Cells, Cultured, DNA, Female, Fibroblasts, Fragile X Syndrome, Humans, Male, Molecular Sequence Data, Nuclear Proteins, Promoter Regions, Genetic, Protein Binding, Sulfites, Genome, Human, Genome, Sequence Analysis, DNA, CpG Islands, DNA Methylation, 5' Untranslated Regions, HCT116 Cells, Mice, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review